当前位置:
X-MOL 学术
›
Theranostics
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells
Theranostics ( IF 12.4 ) Pub Date : 2018-01-01 , DOI: 10.7150/thno.21342 Haoran Liu , Junhua Mai , Jianliang Shen , Joy Wolfram , Zhaoqi Li , Guodong Zhang , Rong Xu , Yan Li , Chaofeng Mu , Youli Zu , Xin Li , Ganesh L. Lokesh , Varatharasa Thiviyanathan , David E. Volk , David G. Gorenstein , Mauro Ferrari , Zhongbo Hu , Haifa Shen
Theranostics ( IF 12.4 ) Pub Date : 2018-01-01 , DOI: 10.7150/thno.21342 Haoran Liu , Junhua Mai , Jianliang Shen , Joy Wolfram , Zhaoqi Li , Guodong Zhang , Rong Xu , Yan Li , Chaofeng Mu , Youli Zu , Xin Li , Ganesh L. Lokesh , Varatharasa Thiviyanathan , David E. Volk , David G. Gorenstein , Mauro Ferrari , Zhongbo Hu , Haifa Shen
Aptamers have the potential to be used as targeting ligands for cancer treatment as they form unique spatial structures.
中文翻译:
一种新型的DNA适体,用于多目标核髓样抑制细胞和肿瘤细胞的双重靶向。
适体具有形成独特的空间结构的潜力,可以用作癌症治疗的靶向配体。
更新日期:2018-01-01
中文翻译:
一种新型的DNA适体,用于多目标核髓样抑制细胞和肿瘤细胞的双重靶向。
适体具有形成独特的空间结构的潜力,可以用作癌症治疗的靶向配体。